Rediscovering Trazodone for the Treatment of Major Depressive Disorder

Trazodone is a triazolopyridine derivative that belongs to the class of serotonin receptor antagonists and reuptake inhibitors (SARIs). The drug is approved and marketed in several countries worldwide for the treatment of major depressive disorder (MDD) in adult patients. In clinical studies, trazod...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagiolini, Andrea, Comandini, Alessandro, Dell’Osso, Mario Catena, Kasper, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693429/
https://www.ncbi.nlm.nih.gov/pubmed/23192413
http://dx.doi.org/10.1007/s40263-012-0010-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693429/
https://www.ncbi.nlm.nih.gov/pubmed/23192413
http://dx.doi.org/10.1007/s40263-012-0010-5

Ejemplares similares